Business Segments · Goodwill, accumulated impairment loss
Health & Biosciences — Goodwill, accumulated impairment loss
International Flavors & Fragrances Health & Biosciences — Goodwill, accumulated impairment loss remained flat by 0.0% to $2.25B in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025Feb 27, 2026
Rolls up toCumulative Gross Losses and Impairments
How to read this metric
A high accumulated balance suggests a history of overpaying for acquisitions or significant deterioration in the segment's market position.
Detailed definition
The total historical amount of goodwill impairment charges recognized for the Health & Biosciences segment. This represe...
Peer comparison
Comparable to 'Accumulated impairment' disclosures in the intangible assets section of financial notes.
Metric ID:
iff_segment_health_biosciences_goodwill_accumulated_impairment_lossHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $2.25B | $2.25B | $2.25B |
| QoQ Change | — | +0.0% | +0.0% |
| YoY Change | — | +0.0% | +0.0% |
Range$2.25B – $2.25B
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak2+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's health & biosciences — goodwill, accumulated impairment loss?
- International Flavors & Fragrances (IFF) reported health & biosciences — goodwill, accumulated impairment loss of $2.25B in Q4 2025.
- What does health & biosciences — goodwill, accumulated impairment loss mean?
- The total historical value of goodwill write-downs for the Health & Biosciences segment.